
BILL HOLDINGS INC
BILLNYSE๐ #1300 by market capEarnings Aug 19 ยท PostUS Equity
$48.16โผ $1.29 (โ2.68%)
Live1hโผ 0.2%
24hโผ 2.7%
7dโผ 0.3%
14dโฒ 1.6%
30dโฒ 12.4%
1yโฒ 23.5%
๐ฆMarket Cap
$4.80B
Small Cap
๐Revenue Growth (YoY)
+12.5%
Healthy
๐Gross Margin
80.7%
High
๐ตFCF Margin
20.4%
Strong
โ๏ธP/S Ratio
3.1x
Fair
Otter Score
48
Weak
๐
Analyst Ratings
Price
$48.16
Total
32
Raised
2
Lowered
4
Avg PT
$51.60
H / L
$55 / $44
| Institution | Action | Rating | Date |
|---|---|---|---|
Truist Securities | Reiterated | Hold | 2026-07-24 |
JP Morgan | Reiterated | Overweight | 2026-06-05 |
Keefe, Bruyette & Woods | Reiterated | Market Perform | 2026-05-12 |
Goldman Sachs | Reiterated | Buy | 2026-05-11 |
Baird | Reiterated | Neutral | 2026-05-11 |
Oppenheimer | Reiterated | Outperform | 2026-05-05 |
Morgan Stanley | Reiterated | Equal Weight | 2026-04-30 |
Canaccord Genuity | Reiterated | Buy | 2026-02-10 |
BTIG | Reiterated | Buy | 2026-02-06 |
Needham | Reiterated | Buy | 2026-02-06 |
Citigroup | Reiterated | Buy | 2026-01-22 |
BMO Capital | Reiterated | Market Perform | 2025-11-07 |
Susquehanna | Reiterated | Positive | 2025-11-07 |
UBS | Reiterated | Buy | 2025-11-07 |
Wolfe Research | Upgraded | Peer Perform โ Outperform | 2025-09-11 |
Piper Sandler | Downgraded | Overweight โ Neutral | 2025-08-28 |
Evercore ISI Group | Reiterated | In Line | 2025-08-28 |
Mizuho | Reiterated | Neutral | 2025-08-28 |
Wells Fargo | Reiterated | Underweight | 2025-05-09 |
Seaport Global | Downgraded | Buy โ Neutral | 2025-04-17 |
Keybanc | Reiterated | Overweight | 2025-03-18 |
Jefferies | Reiterated | Buy | 2024-04-29 |
Exane BNP Paribas | Upgraded | Underperform โ Neutral | 2024-03-13 |
William Blair | Downgraded | Outperform โ Market Perform | 2023-11-03 |
B of A Securities | Reiterated | Buy | 2023-08-18 |
Deutsche Bank | Reiterated | Buy | 2023-06-29 |
Credit Suisse | Reiterated | Outperform | 2023-05-05 |
SMBC Nikko | Downgraded | Outperform โ Neutral | 2023-02-03 |
Berenberg | Reiterated | Hold | 2021-04-08 |
KeyBanc | Reiterated | Overweight | 2021-02-05 |
Guggenheim | Reiterated | Buy | 2020-10-06 |
First Analysis | Reiterated | Outperform | 2020-03-11 |
One row per institution, most recent rating